Kits
New laminin isoform kit simplifies cell culture workflow
Nov 01 2024
AMSBIO has launched the iMatrix Palette, a comprehensive kit designed to streamline cell culture and differentiation workflows for researchers working with ES/iPS cells. The kit includes all variants of AMSBIO’s iMatrix recombinant laminin E8 fragment isoforms, helping researchers save time, reduce costs, and improve reproducibility.
Culturing human stem cells and iPS cells under feeder-free conditions requires ECM proteins to promote cell adherence to plasticware. Unlike traditional laminin-based options, iMatrix E8 fragments are only 20% of full-length laminin, yet they retain all integrin binding sites, enabling improved cell adhesion and expansion. Studies by researchers at Kyoto University have demonstrated the effectiveness of iMatrix E8 fragments in supporting cell culture and growth. The iMatrix series of recombinant laminin isoforms set the benchmark for differentiation of iPSCs into ectoderm, mesoderm, and endoderm.
The iMatrix Palette contains a vial of each laminin E8 variant, allowing researchers to test and choose the optimal isoform for their specific applications. This flexibility enhances experimental accuracy and outcomes while enabling efficient pre-mixing and pre-coating protocols. The kit consolidates all necessary variants in one package, eliminating the need to purchase multiple individual variants and providing a more cost-effective solution for researchers.
The iMatrix Palette kit offers unmatched versatility and control over cell behaviour, improving reproducibility and efficiency in stem cell research and differentiation protocols.
More information online
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan